Viewing nowMetpol M Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201403748 · Approved 2014.08.13 · Insurance code 622801930
Treatment of type 2 diabetes mellitus
This medicine is used for adults with type 2 diabetes who do not achieve sufficient blood sugar control with diet and exercise alone, especially in those who are overweight. It can also be used alone or in combination with insulin to help control blood sugar in children over 10 years old and adolescents. This medicine can be used in conjunction with other oral hypoglycemic agents, providing flexibility in treatment. It helps to effectively control blood sugar for various age groups and treatment scenarios. Therefore, it is used to improve blood sugar management in patients with type 2 diabetes.
The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. This medication must be started at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses daily and take with meals; the maximum daily dose is 2550mg. At the start of treatment and when adjusting the dose, fasting blood glucose should be measured to assess the response to treatment with this medication and identify the minimum effective dose. Glycated hemoglobin levels should be measured at approximately 3-month intervals. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term treatment with this medication may be sufficient to achieve an adequate effect. Patients with renal impairment This medication may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medication must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.
This medicine can cause severe lactic acidosis or hypoglycemia, which could potentially lead to death, and thus should be used with utmost caution. It should not be administered to patients with moderate to severe renal impairment or acute conditions affecting kidney function, such as dehydration, severe infections, or acute myocardial infarction. It is also safe not to use this medicine in patients with acute heart failure or unstable cardiac conditions. Before and after exams using iodinated contrast agents, administration of this medicine must be discontinued and can only be resumed after renal function has returned to normal. Patients with a history of allergic reactions to this medicine or biguanides should avoid taking it. This medicine is not suitable for patients with type 1 diabetes or metabolic acidosis, including diabetic ketoacidosis and lactic acidosis. Patients with severe infections or significant traumatic systemic disorders must suspend intake until oral intake is feasible and renal function has normalized. In cases of surgery, especially when food and fluid intake is limited, the medicine should be discontinued 48 hours prior to the surgery and can be resumed only after confirming normal renal function post-surgery. Patients in poor nutritional status or frailty, and those with pituitary or adrenal dysfunction must be monitored closely. Patients with hepatic impairment, pulmonary infarction, or severe pulmonary dysfunction, those who consume excessive alcohol, or those with dehydration, diarrhea, or vomiting, should avoid this medicine. It is safest not to use this medicine during pregnancy if there is a risk of placental insufficiency, preeclampsia, or intrauterine growth retardation. Patients with irregular eating habits, insufficient meal intake, or who engage in intense physical activity, and those with potential drug interactions should be administered this medicine cautiously. While using this medicine, if symptoms of lactic acidosis such as fatigue, muscle pain, difficulty breathing, or abdominal pain occur, report immediately to healthcare personnel, and discontinue medication. Gastrointestinal side effects (diarrhea, nausea, vomiting) may commonly occur but are usually transient and can be alleviated by taking the medicine with food or gradually increasing the dosage. This medicine can accumulate based on renal function, so renal function tests should be done before administration and regularly thereafter. If there is a rapid decline in renal function, immediate discontinuation is necessary. Alcohol can impact the metabolism of this medicine increasing the risk of lactic acidosis; therefore, excessive drinking should be avoided while taking this medicine. Vitamin B12 deficiency may occur, so serum vitamin B12 levels should be monitored regularly. The risk of hypoglycemia is low when taken alone, but it can occur when combined with other hypoglycemic agents or insulin or in cases of insufficient meal intake, requiring vigilance. Elderly patients are at high risk of decreased renal function, necessitating dosage adjustments and regular renal function assessments. Pregnant women should use this medicine only when necessary for blood sugar management before and during pregnancy, with close monitoring of fetal growth. When breastfeeding, as this medicine can be excreted in breast milk, careful consideration must be given to whether to continue breastfeeding or to discontinue the medication. In cases of overdose, there is a risk of lactic acidosis, so in suspected cases, immediate treatment at a healthcare facility is required, and blood dialysis may be helpful. This medicine does not cause weight gain, making it advantageous for diabetic patients who need to manage their weight, and it can be taken safely through consistent blood sugar and renal function tests.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in an airtight container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness and prevent degradation.
White round film-coated tablet
500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.